CORT Corcept Therapeutics PE ratio, current and historical analysis
As at Mar 13, 2025, the CORT stock has a price-to-earnings ratio of 40.63. This is based on the current EPS of $1.35 and the stock price of $54.85 per share. An increase of 36% has been recorded in the PE ratio compared to the average of 30.0 of the past four quarters.
CORT PE ratio history
The mean historical PE ratio of Corcept Therapeutics over the last nine years is 47.6. The current 40.63 price-to-earnings ratio is 15% less than the historical average. In the past nine years, CORT's PE ratio reached its highest point in the Jun 2016 quarter at 546, with a price of $5.46 and an EPS of $0.01. The Sep 2018 quarter saw the lowest point at 10.54, with a price of $14.02 and an EPS of $1.33.
Corcept Therapeutics PE ratio by year
Maximum annual increase: 92.62% in 2020
Maximum annual decrease: -84.73% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 37.33 | 17.24% | $50.39 | $1.35 |
| 2023 | 31.84 | 48.92% | $32.48 | $1.02 |
| 2022 | 21.38 | 4.75% | $20.31 | $0.95 |
| 2021 | 20.41 | -28.21% | $19.8 | $0.97 |
| 2020 | 28.43 | 92.62% | $26.16 | $0.92 |
| 2019 | 14.76 | -28.18% | $12.1 | $0.82 |
| 2018 | 20.55 | 29.73% | $13.36 | $0.65 |
| 2017 | 15.84 | -84.73% | $18.06 | $1.14 |
| 2016 | 103.71 | N/A | $7.26 | $0.07 |
| 2015 | N/A | N/A | $4.98 | -$0.06 |
| 2014 | N/A | N/A | $3 | -$0.31 |
| 2013 | N/A | N/A | $3.21 | -$0.46 |
| 2012 | N/A | N/A | $1.43 | -$0.41 |
| 2011 | N/A | N/A | $3.42 | -$0.39 |
| 2010 | N/A | N/A | $3.86 | -$0.38 |
Corcept Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 37.33 | 9.7% | $50.39 | $1.35 |
| Sep 2024 | 34.03 | 27.79% | $46.28 | $1.36 |
| Jun 2024 | 26.63 | 21.6% | $32.49 | $1.22 |
| Mar 2024 | 21.9 | -31.22% | $25.19 | $1.15 |
| Dec 2023 | 31.84 | 2.84% | $32.48 | $1.02 |
| Sep 2023 | 30.96 | 23.84% | $27.25 | $0.88 |
| Jun 2023 | 25 | 1.58% | $22.25 | $0.89 |
| Mar 2023 | 24.61 | 15.11% | $21.66 | $0.88 |
| Dec 2022 | 21.38 | -9.94% | $20.31 | $0.95 |
| Sep 2022 | 23.74 | 1.84% | $25.64 | $1.08 |
| Jun 2022 | 23.31 | 2.46% | $23.78 | $1.02 |
| Mar 2022 | 22.75 | 11.46% | $22.52 | $0.99 |
| Dec 2021 | 20.41 | -5.64% | $19.8 | $0.97 |
| Sep 2021 | 21.63 | -17.41% | $19.68 | $0.91 |
| Jun 2021 | 26.19 | -5.31% | $22 | $0.84 |
CORT average PE ratio chart
The current PE ratio of CORT is above its 3 and 5-year historical averages, but it is lower than the 10-year average.
CORT PE vs peers
When compared to its peers LLY and MNKD, CORT's PE ratio is lower, but it is higher than JNJ's and MRK's. Corcept Therapeutics's PE ratio is trading above the peer group average of 32.78.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 14 | $239.11B |
| PFE Pfizer Inc | 18.07 | $145.42B |
| NVS Novartis AG | 18.41 | $215.28B |
| JNJ Johnson & Johnson | 27.88 | $392.03B |
| BMRN Biomarin Pharmaceutical Inc | 31.39 | $13.47B |
| CORT Corcept Therapeutics Inc | 40.64 | $5.79B |
| MNKD Mannkind Corp | 51.6 | $1.57B |
| LLY ELI LILLY & Co | 68.66 | $765.65B |
| BMY Bristol Myers Squibb Co | N/A | $122.43B |
| ESPR Esperion Therapeutics Inc | N/A | $302.71M |
Frequently asked questions
What is Corcept Therapeutics's PE ratio?
The price to earnings ratio for CORT stock is 40.63 as of Mar 13, 2025.
What is the 3-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 3 years, the average PE ratio for CORT stock is 26.96.
What is the 5-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 5 years, the average PE ratio for CORT stock is 24.8.
What is the highest PE ratio for CORT?
In the last nine years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 546.
How does the current PE ratio for CORT compare to its historical average?
CORT's current price to earnings ratio is 15% below its 9-year historical average.
How is CORT's PE ratio calculated (Corcept Therapeutics PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Mar 13, 2025), Corcept Therapeutics's stock price is $54.85. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.35. Therefore, Corcept Therapeutics's price to earnings ratio for today is 40.63. PE RATIO(40.63) = STOCK PRICE($54.85) / TTM EPS($1.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.